BOMESI Foundation Opens Fifth Accelerator Cohort For Diverse-Owned Media Publishers And Creators 
Ynvisible Advances Commercial Program with Sapphiros, Announces CFO Appointment and Adoption of Semi-Annual Financial Reporting 
Airwheel SE3SX AI Wheel Luxury Suitcase Wins 2026 WGA for Smart Electric Riding Carry-On Hand Luggage 
Syntheia Signs Definitive Agreement for Sale of Call Center Assets and Announces Shares for Debt Transaction William Kivit Launches Website
The automotive technician and entrepreneur is delighted to inform the public about the premiere of…
Pharnext to Host 2021 Hybrid Research & Development Day
Attendees invited to join in person in New York, or virtually via a simultaneous live…
AlzeCure Pharma Develops Novel Analgesic Drug Based on Nobel Prize-Winning Discoveries
STOCKHOLM, SE / ACCESSWIRE / October 6, 2021 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB…
PixelMax launches immersive 3D platform to solve hybrid working challenge
UK tech start-up extends digital events offering to include dynamic virtual hybrid workplaces Manchester, UK,…
Orbus Software rapidly expands North American operations as demand for Enterprise Architecture platforms soars globally
Continues global expansion with 93% new bookings growth following 60 new customers added to Orbus…
Beyond by BearingPoint Joins AWS ISV Accelerate Program
Program participation will enable Beyond’s customers to increase operational agility, accelerate speed to market, and…
Eurobio Scientific Receives a $430,000 Milestone Payment From Allergan
EUROBIO SCIENTIFIC RECEIVES A $430,000 MILESTONE PAYMENT FROM ALLERGAN Transition to clinical stage of a…
Covicept Therapeutics initiates a Phase 2 clinical study with PJS-539, an oral small molecule for the treatment of patients with COVID-19 (SARS-CoV-2)
Covicept Therapeutics initiates a Phase 2 clinical study with PJS-539, an oral small molecule for…
Biophytis to Host Virtual KOL Event on Sarconeos (BIO101) on its Lead Projects in COVID-19 and Sarcopenia
PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext…
Addex to Present at the Investors’ Day hosted by Voxia Communication
Geneva, Switzerland, October 6, 2021 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company…
Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week
Encouraging preclinical data support continued advancement of SZN-1326 towards first in human clinical studies in…
Eledon Pharmaceuticals Announces Upcoming Presentation on AT-1501 at the Virtual 2021 International Pancreas and Islet Transplantation Association Congress
IRVINE, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
Neuronetics Announces Commercial Agreement with Success TMS
MALVERN, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical…
Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference
FOSTER CITY, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
CRISPR Therapeutics to Host Virtual Event Highlighting CTX110™ Clinical Data
–Management to host conference call and webcast on October 12th at 4:30 p.m. ET- ZUG,…
Oncternal Therapeutics Announced Pre-Clinical Data from ONCT-534, an Androgen Receptor N-Terminal-Domain-Binding Small Molecule Degrader, Was Accepted for Virtual Poster Presentation at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Androgen Receptor (AR) inhibition is an important therapeutic approach for the treatment of Castration-Resistant Prostate…
Shockwave Medical to Report Third Quarter 2021 Financial Results on November 8, 2021
SANTA CLARA, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ: SBBP) (the…
SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe
Prospective joint venture will accelerate precision medicine in Europe by harnessing innovations in high-throughput drug…
Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Oct. 05, 2021 (GLOBE NEWSWIRE) — Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW)…